Profiles of IgE Sensitization to Der f 1, Der f 2, Der f 6, Der f 8, Der f 10, and Der f 20 in Korean House Dust Mite Allergy Patients by 諛뺢꼍�씗 et al.
© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory DiseasePB http://e-aair.org 483http://e-aair.org
INTRODUCTION
The concept of component-resolved diagnosis (CRD) for aller-
gy diagnosis was first introduced in 1999.1 CRD utilizes purified 
allergens, which are recombinant or native, to identify causative 
allergens in individual patients. It allows the physician to distin-
guish genuine sensitization from false positivity by cross-reactivi-
ty with other components. It can also discriminate clinically sig-
nificant sensitization from insignificant sensitization, such as 
easily denatured allergens in patients with food allergies. There-
by, it enables identification of culprit allergens, can often help se-
lect patients who will benefit from allergen-specific immuno-
therapy,2 and allows appropriate recommendations of what al-
lergens to avoid. In practice, CRD has been found to be useful in 
diagnosis of food allergies such as peanut, wheat, and buckwheat 
allergies, in addition to bee sting anaphylaxis or pollen allergy. 
However, CRD studies of house dust mite allergens are lacking.
A significant correlation between the results of specific IgEs to 
group 1 or 2 major allergens and the skin prick test has been re-
ported, indicating that CRD might be useful in HDM allergies.3 
Variable profiles of IgE reactivity among HDM allergic patients 
were first reported in Europe.4 A high prevalence of an anti-Der p 
4 IgE response, rather than an anti-Der p 1 and Der p 2 response, 
was described in Australian Aboriginals, indicating distinct al-
lergic responses, possibly in response to different infections.5 
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Der p 10 (tropomyosin) was suggested as a diagnostic marker of 
broad sensitization in HDM allergy to discriminate between 
subjects sensitized exclusively to the major allergens (Der p 1 
and Der p 2) and those with a broad sensitization profile.6-8 
Moreover, polysensitization to multiple HDM allergens were 
correlated with the complexity of the allergic phenotype in chil-
dren in a tropical environment.9
However, IgE reactivity of some allergens from D. farinae has 
not been investigated, although the allergenicity of counterpart 
allergens from D. pteronyssinus has been described. For exam-
ple, Der f 8 and Der f 20 have not been officially listed as aller-
gens by the allergen nomenclature subcommittee (www.aller-
gen.org) to date. 
In this study, we aimed to determine the profile of IgE reactiv-
ity in Korean HDM allergic patients and to compare the sensiti-
zation profiles of subjects suffering from respiratory allergy and 
AD using recombinant Der f 1 (cysteine protease), Der f 2 (MD-
2 homologue), Der f 6 (chymotrypsin), Der f 8 (glutathione S-
transferase), Der f 10 (tropomyosin), and Der f 20 (arginine ki-
nase). Furthermore, we investigated the usefulness of CRD in 
HDM allergy.
MATERIALS AND METHODS
Patient selection and serum samples
Serum samples were collected from HDM allergy patients in 
the Allergy-Asthma Clinic at Severance Hospital, Seoul, Korea. 
Patient consent was obtained before blood collection. Specific 
IgE to Dermatophagoides farinae was determined using the Im-
munoCAP system (Phadia, Uppsala, Sweden). One hundred 
twenty-nine subjects (62 males and 67 females, mean age 34 
years; range, 5 to 79 years) were enrolled in this study. Of 40 sub-
jects with asthma, 15 were diagnosed with asthma (AS) only, 23 
with AS and allergic rhinitis (AR), and 2 with AS, AR, and AD. 
Among 52 patients diagnosed with AR, 27 had AR only, 23 had 
AR with AS, and 2 had AR, AS, and AD. Of 64 individuals with 
AD, 58 were diagnosed with AD only and 6 were diagnosed with 
AD, AR, and AS. Four of these patients were also diagnosed 
with allergic conjunctivitis (AC). However, statistical analysis 
was not done for patients with AC due to the small size of this 
group. Subjects were assigned to the respiratory allergy group, 
AD group, or both allergy groups for further analysis (Fig. 1). 
This study was approved by the institutional review board of 
our institute (4-2013-0397).
Allergen extract
Allergen extract was prepared as previously described.10,11 
Briefly, allergens were extracted with bicarbonate buffer from 
HDM bodies which were purified using saturated salt water. 
The extract was extensively dialyzed against distilled water and 
lyophilized. For the experiments, the extract was reconstituted 
in a phosphate buffer, aliquoted, and kept at -70°C until use. 
Protein concentration was determined by Bradford assay (Bio-
Rad, Hercules, CA, USA).
Production of recombinant allergens
Recombinant Der f 1 (proDer f 1) was produced as described 
by Yasuhara et al. with slight modification.12 Reverse transcrip-
tase (RT)-PCR was carried out using oligonucleotide primers 
(forward: 5’-CTCGAGCGTCCAGCTTCAATCAAAACT-3’, re-
verse: 5’-GCGGCCGCTTAGTGATGGTGATGGTGATGCGCGC-
CGCGTGATGGTG-3’) to amplify Der f 1.0101, which is the pre-
dominant isoform in Korea.13 The underlined sequences corre-
sponded to Xho I and Not I sites, and codons for 6 histidines 
were also incorporated in the reverse primer. PCR products 
were ligated into the pCR4-TOPO vector (Invitrogen Life Tech-
nologies, Carlsbad, CA, USA). To avoid hyperglycosylation, the 
53rd amino acid (N-glycosylation site) was mutated from Asp 
to Gln using the QuikChange®II Site-Directed Mutagenesis Kit 
(Stratagene, La Jolla, CA, USA). The mutated plasmid was sub-
cloned into the Xho I and Not I sites of the pPIC9 vector (Invit-
rogen). Subsequently, Sal I-linearized plasmid was transformed 
into GS115 cells using the PichiaEasyComp kit (Invitrogen). 
His+ transformants were selected on RDB plates (1.34% yeast 
nitrogen base without amino acids, 1 M sorbitol, 1% dextrose, 4 
×10-5% biotin, and 0.005% each of L-glutamic acid, L-methio-
nine, L-lysine, L-leucine, and L-isoleucine). A clone was select-
ed, and cells were grown for 4 days at 220 rpm; 0.05% methanol 
(v/v) was added every 24 hours. Culture supernatant was har-
vested by centrifugation and concentrated by ammonium sul-
fate precipitation (50%). Precipitates were dissolved in 10 mM 
imidazole, 300 mM NaCl, and 50 mM sodium phosphate at pH 
8.0. Recombinant proteins were purified using Ni-nitrilotriace-
tic (NTA) acid resin (Qiagen, Valencia, CA, USA) according to 
the manufacturer’s instructions. Mature Der f 1 was obtained 
by an auto-activation (cleavage of prosequence) process by di-
alysis against 100 mM acetate buffer (pH 4.0) at 4°C for 48 
hour.12 After this activation process, recombinant Der f 1 pro-
tein was dialyzed against 20 mM Tris-HCl at pH 8.0.
Fig. 1. Patient groups with HDM allergies. Respiratory allergy group consisted 
of subjects diagnosed with asthma (AS), allergic rhinitis (AR), and/or allergic 
conjunctivitis (AC), while the skin allergy group consisted of those diagnosed 
with atopic dermatitis (AD).
Respiratory allergy
AR, AS (AC) AD
Skin allergy
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Both respiratory and skin allergies
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Der f 2.0102 was produced because it is the predominant 
isoform in Korea.13 DNA fragments were amplified by PCR 
(forward primer: 5’-GATCAAGTCGATGTTAAAG-3’, reverse: 
5’-TTATCACGGATTTTACCATG-3’) using a clone ligated into a 
plasmid vector (pCR4-TOPO) (Invitrogen) as template, and 
these fragments were then subcloned into the pEXP-5NT/
TOPO vector (Invitrogen). Der f 6 was amplified by RT-PCR 
with specific primers (forward: 5’-GATGCACGATTTCCAC-
GC-3’ reverse: 5’-TCAAACAATGTTTTTTGT-3’). PCR-products 
were cloned into the pEXP-5NT/TOPO vector. Der f 8 was also 
amplified by RT-PCR with primers (forward: 5’-ATGGCTC-
CAAAAACAATTCTT-3’, reverse: 5’-TTATGCATATGTACCATTC-
CA-3’), and then cloned into the pEXP-5NT/TOPO vector. Der f 
10 was PCR-amplified from the pGEM-T Easy vector (Promega) 
and subcloned into the pET28b expression vector (Novagen, 
Madison, WI, USA) as previously described.14
For production of recombinant Der f 20, PCR was performed 
with specific primers (forward primer: 5’-CCATGGTTGAT-
CAAGCTGTCATCG-3’, reverse primer: 5’-CTCGAGCATG-
GATTTTTCAATTTTAAT C-3’) designed on the basis of the 
known cDNA sequence of arginine kinase from Dermatopha-
goides farinae in GenBank (accession no. AY211951). Under-
lined sequences correspond to Nco I and Xho I sites, respective-
ly. Amplified PCR product was ligated into the expression vec-
tor pET28b (Novagen) after digestion with Nco I and Xho I re-
striction endonucleases. 
All recombinant allergens except Der f 1 were expressed in 
Escherichia coli BL21 (DE3) and purified using Ni-agarose resin 
(Qiagen). Der f 2, Der f 6, and Der f 20 were isolated from inclu-
sion bodies using 6 M urea. Der f 8 and Der f 10 were purified 
from soluble fractions. The concentrations of purified proteins 
were determined by Bradford assay, and a 10-μg aliquot of each 
protein was run on a 15% polyacrylamide gel containing sodi-
um dodecyl sulfate under reducing conditions.
Measurement of specific IgEs by ELISA
Levels of allergen-specific serum IgEs were measured by ELI-
SA. Each allergen (2 μg/mL for recombinant protein and 10 μg/
mL for allergen extract) in 50 mM carbonate buffer (pH 9.6) was 
coated onto a microtiter plate and kept at 4°C overnight. After 
blocking with 3% skim milk in phosphate-buffered saline con-
taining 0.05% Tween 20 (PBST), plates were incubated for 1 
hour with serum samples at 1:4 dilution. Subsequently, plates 
were incubated with biotinylated goat anti-human IgE at 1:1,000 
dilution (Vector, Burlingame, CA, USA) for 1 hour and streptav-
idin-peroxidase (Sigma-Aldrich, Sydney, Australia) at 1:1,000 
dilution for the detection of IgE antibodies. Plates were washed 
three times with PBST between each step. Color was developed 
using 3,3’5,5’-tetramethylbenzidine substrate solution (Kirkeg-
aard Perry Laboratories, Gaithersburg, MD, USA), and then ab-
sorbance at 450 nm was measured. The mean plus 2 SD of ab-
sorbance values of sera from non-sensitized subjects was used 
as the cutoff value.
Statistical analysis
Multivariate regression analysis was performed to analyze sta-
tistical significance. Correlations of IgE antibody responses be-
tween groups of patients were assessed by Pearson’s χ2 test and 
Fisher’s exact test. Correlations between the numbers of subjects 
diagnosed with allergies according to allergy type, and the num-
ber of sensitized allergens were analyzed by ANOVA with Bonfer-
roni correction. SPSS v18.0 was utilized, and a result was consid-
ered statistically significant when the P value was less than 0.05.
RESULTS
IgE reactivity prevalence to recombinant HDM allergens 
All expressed recombinant allergens showed an apparent sin-
gle band with the expected molecular weight on SDS-PAGE 
analysis. However, Der f 2 appeared as a strong dimer along with 
a monomer (Fig. 2).
Subjects suffering from respiratory allergies (AR, AS, and/or 
AC) and/or from AD were analyzed for IgE reactivity to recom-
binant Der f 1, Der f 2, Der f 6, Der f 8, Der f 10, and Der f 20 by 
ELISA (Fig. 3). As expected, most subjects had IgE responses to 
group 1 and 2 allergens. Der f 1- and Der f 2-specific IgEs were 
found in 86.4% and 89.4% of respiratory allergic patients (n =  
65), respectively. Only 4.6 to 6.2% of HDM respiratory allergy 
patients had specific IgE to each minor allergen (Der f 6, Der f 8, 
Der f 10, and Der f 20). Anti-group 1 and 2 IgEs were found in 
72.4% and 71.0% of AD patients (n=58), respectively. Only 5.2 
to 12.1% of the AD patients had specific IgEs to these minor al-
lergens. When all HDM allergy patients were considered, 79.1% 
and 79.1% of patients had IgEs specific to both group 1 and 2 
major allergens, respectively, while only 6.2% to 9.3% of sub-
Fig. 2. Production of recombinant HDM allergens. Purified each allergen (10 μg) 
were separated on a 15% polyacrylamide gel containing sodium dodecyl sul-
fate under reducing conditions. M, molecular mass standard; 01, recombinant 
Der f 1; 02, recombinant Der f 2; 06, recombinant Der f 6; 08, recombinant Der f 
8; 10, recombinant Der f 10; 20, recombinant Der f 20.
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jects had IgE specific to each minor allergen. 
Diagnostic sensitivity of various combinations of recombinant 
allergens
Diagnostic sensitivity according to combinations of various re-
combinant allergens was determined (Table 1). Der f 2 showed 
the highest diagnostic sensitivity in respiratory allergic patients 
(89.4%). The combination of 2 major allergens increased the 
sensitivity to 92.3%. The combination of all minor allergens with 
major allergens only resulted in the diagnosis of one additional 
subject. Approximately 84.5% of AD patients could be diagnosed 
as HDM allergy by the combination of 2 major allergens. Minor 
allergens did not increase sensitivity. In patients with both 
HDM-sensitized respiratory allergy and AD, neither Der f 1 
(66.7%) nor Der f 2 (50.0%) was useful for diagnosis.
IgE sensitization profile and disease entity 
To investigate the usefulness of CRD for the differentiation of 
each HDM-related allergic disease, the relationship between 
sensitization profile and disease entity were examined statisti-
Fig. 3. IgE reactivities of recombinant allergens. Absorbance range (A) and positive rate (B) to each allergen are plotted. The bottom and top edges of the box indi-
cate the intra-quartile range (25th and 75th percentiles, respectively). The horizontal line inside the box indicates the median value. Whiskers denote the 10th and 
90th percentiles.
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Table 1. IgE binding frequencies to each allergen
Subjects Der f 1 Der f 2 Der f 6 Der f 8 Der f 10 Der f 20
Respiratory allergy 57/66 (86.4%) 59/66 (89.4%) 4/66 (6.1%) 4/66 (6.1%) 4/66 (6.1%) 3/66 (4.5%)
Skin allergy 44/61 (72.1%) 43/61 (70.5%) 7/61 (11.5%) 3/61 (4.9%) 4/61 (6.6%) 4/66 (6.1%)
Both symptom 4/6 (66.7%) 3/6 (50.0%) 1/6 (16.7%) 1/6 (16.7%) 1/6 (16.7%) 2/6 (33.3%)
Total 105/133 (78.9%) 105/133 (78.9%) 12/133 (9.0%) 8/133 (6.0%) 9/133 (6.8%) 9/133 (6.8%)
Table 2. Serum IgE responses to mite allergens and clinical diagnosis
Number of allergen-specific IgEs
No. %
0 1 2 3 4 5 6
Single diagnosis 100 77.5
   Asthma (AS) 2 2 8 2 1 15 11.6
   Allergic rhinitis (AR) 1 2 21 0 3 27 20.9
   Atopic dermatitis (AD) 9 13 25 8 1 2 58 45.0
Two diagnoses 27 20.9
   AS+AR 1 3 16 2 1 23 17.8
   AR+AD 2 2 4 3.1
Three diagnoses 2 1.6
   AS+AR+AD 1 1 2 1.6
Total 15 23 70 12 6 2 1 129 100
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cally (Table 2). HDM-sensitized respiratory allergic patients had 
Der f 2-specific IgE more frequently than AD patients (P=  
0.013). The mean number of sensitized allergens tested in all 
enrolled subjects was 1.85, and it was not different between the 
HDM respiratory allergy and AD groups. There was no statisti-
cally significant relationship between the number of sensitized 
allergens per patient and the number of disease entities such as 
AS, AR, AC, or AD.
DISCUSSION
HDM is one of the most frequent causes of respiratory allergy 
and AD, and 24 groups of allergens have been described to 
date.15 We investigated patient sensitization profiles to recom-
binant HDM allergens. Der f 2 allowed diagnosis of the vast ma-
jority of respiratory allergic patients (89.4%), while the addition 
of Der f 1 increased the sensitivity slightly (92.3%). However, the 
combination of these 2 allergens was less efficient for the diag-
nosis of AD subjects. These subjects had a sensitivity of 72.4% 
and 71.0% to Der f 1 and Der f 2, respectively. The combination 
of two major allergens enabled diagnosis of 84.5% of AD pa-
tients. We did not analyze patients suffering from both entities 
because only 6 of these patients were enrolled. Fifteen subjects 
did not show a positive reaction to any of the allergens tested. 
Specific IgE to D. farinae (d2) was low (0.89 to 15.6 kU/L) in 
these 15 patients, except for 1 serum sample (56 kU/L) as mea-
sured by ImmunoCAP. Therefore, sensitivity of ELISA in this 
study may influence the diagnostic sensitivity using recombi-
nant allergens. The lower IgE reactivity to Der f 1 (62/103, 60.2%) 
and Der f 2 (63/103, 61.2%) reported in a previous study may be 
due to the quality of allergens produced.16
We examined whether sensitization to a specific allergen is 
disease-specific or not. No correlation was found between the 
sensitization to specific HDM allergens and the disease entity; 
there was also no relationship between the number of sensi-
tized allergens per patient and the number of disease entities 
per patient (Table 2). Therefore, the hypothesis that the more 
allergens a subject is sensitized, the more likely that a subject 
suffers from multiple disease entities is questionable.9
Among 25 patients with sensitization to minor allergens, only 
1 subject (4.0%) showed negative responses to the 2 major al-
lergens. Among 9 subjects that showed IgE reactivity to Der f 10, 
7 (77.8%) exhibited positive responses to the other minor aller-
gens. However, 16 subjects were sensitive to the other minor al-
lergens without reactivity to Der f 10. This result implies that 
Der f 10 is not suitable for use as a broad sensitization marker. 
Minor allergens analyzed in this study are known to be highly 
cross-reactive, and sensitization to Der f 10 may imply a history 
of infection to parasites or cross-reactions with other allergens. 
Der f 10, tropomyosin, is a well-known invertebrate pan-aller-
gen.17 Infection with intestinal parasites, such as Ascaris lumbri-
coides, has been reported to be associated with IgE reactivity to 
tropomyosin.18,19 Cross-reactivity of arginine kinase (Der f 20) 
has also been described.20 This is the first study to report the al-
lergenicity of Der f 20. Several lines of evidence indicate that 
Der f 8, glutathione S-transferase, is a cross-reactive allergen 
between parasites and mites, and even cockroaches.21,22
Der f  4, Der f  5, Der f  7, and Der f  21 are known as mid-range 
allergens that bind IgE in 30% to 50% of mite allergic patients.23,24 
However, these allergens were not included in this study. Fur-
ther analysis with these mid-range allergens is necessary to in-
vestigate the usefulness of CRD in house dust mite allergy.
In conclusion, Der f 2 had diagnostic value in respiratory al-
lergic patients. The combination of Der f 1 and Der f 2 allowed 
diagnosis of 92.3% of respiratory allergic patients. Of patients 
with AD, 71.0% had specific IgE to Der f 2, and sensitivity in-
creased to 84.5% when sensitivity to Der f 1 was included. These 
data imply that careful selection of patient groups could im-
prove diagnostic sensitivity using recombinant allergens. How-
ever, we did not find any association between sensitization to a 
specific allergen and specific disease entity. Furthermore, Der f 
10 was not useful as a marker for broad sensitization to minor 
allergens. Future studies should be done for assessing the use-
fulness of CRD in HDM allergy using the other recombinant 
HDM allergens not tested in this study.
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